Report Details:
15 Companies Covered
80 Pages
Pune, India, 2024 /MRFR Press Release/- Market research future has a Half Cooked Research report on Middle-East and Africa Colorectal Cancer Market.
MEA Colorectal Cancer Market Highlights
The MEA Colorectal Cancer Market is expected to reach USD 2.43 Billion by 2032 at 6.11% CAGR during the forecast period 2024-2032. Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers can also known as colon cancer or rectal cancer, depending on where they start. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, Diarrhea, Pains in the abdomen, Vomiting, and feeling tired all the time.
Globally, around 1.4 million people diagnosed in 2014, in Middle-East and Africa approximately 5000 are suffering from Colorectal Cancer throughout Middle-East and Africa. About 80% of orphan disorders are genetic origin. Rising consumer awareness and continuous development of treatment for Colorectal Cancer are driving the growth for the Middle-East and Africa colorectal cancer market. Major drugs manufacturers are investing amount of money for R & D to find cure for colorectal cancer. Increasing funding and overall increased expenditure for healthcare, developing infrastructure, and expanded insurance coverage are leading the growth for Middle-East and Africa Colorectal Cancer. There are several factors which are prohibiting the growth of the market such as extremely high cost of cancer treatment and drugs, lack of early diagnosis, lack of awareness and healthcare facilities particularly in African countries etc.
Market Players:
Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (US), Novartis AG(Switzerland), Abbott (US), Beckman Coulter Inc. (US), Debiopharm Group (Switzerland), AbbVie Inc. (US), Bayer AG (Germany)
Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of MEA Colorectal Cancer Market Research Report
Regional Analysis:
Considering the Middle-East and Africa Colorectal Cancer Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Colorectal Cancer. Moreover Saudi Arabia market is also growing and second largest market for Patient monitoring devices. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Colorectal Cancer during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.
Market Segmentation:
Middle-East and Africa Colorectal Cancer market has been segmented on the basis of type which Adenocarcinomas, Carcinoid tumors, Gastrointestinal stromal tumors (GISTs), Lymphomas, Sarcomas, and others. On the basis of diagnosis the market is segmented into Faecal Occult Blood Test, Colonoscopy, Virtual Colonoscopy, Stool DNA test, Digital Rectal Examination, Flexible Sigmoidoscopy, Biopsy, Magnetic resonance imaging (MRI), and Others. On the basis of treatment type market is segmented into Surgery, Radiation Therapy, Chemotherapy, targeted drug therapy, and others.